<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34193885</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders.</ArticleTitle><Pagination><StartPage>13562</StartPage><MedlinePgn>13562</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13562</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-92112-3</ELocationID><Abstract><AbstractText>Motor neuron disorders (MND) include a group of pathologies that affect upper and/or lower motor neurons. Among them, amyotrophic lateral sclerosis (ALS) is characterized by progressive muscle weakness, with fatal outcomes only in a few years after diagnosis. On the other hand, primary lateral sclerosis (PLS), a more benign form of MND that only affects upper motor neurons, results in life-long progressive motor dysfunction. Although the outcomes are quite different, ALS and PLS present with similar symptoms at disease onset, to the degree that both disorders could be considered part of a continuum. These similarities and the lack of reliable biomarkers often result in delays in accurate diagnosis and/or treatment. In the nervous system, lipids exert a wide variety of functions, including roles in cell structure, synaptic transmission, and multiple metabolic processes. Thus, the study of the absolute and relative concentrations of a subset of lipids in human pathology can shed light into these cellular processes and unravel alterations in one or more pathways. In here, we report the lipid composition of longitudinal plasma samples from ALS and PLS patients initially, and after 2&#xa0;years following enrollment in a clinical study. Our analysis revealed common aspects of these pathologies suggesting that, from the lipidomics point of view, PLS and ALS behave as part of a continuum of motor neuron disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Area-Gomez</LastName><ForeName>Estela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departments of Neurology, Columbia University Medical Center, Room P&amp;S 4-443, 630 West 168th Street, New York, NY, 10032, USA. eag2118@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larrea</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departments of Neurology, Columbia University Medical Center, Room P&amp;S 4-443, 630 West 168th Street, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Departments of Neurology, Columbia University Medical Center, Room P&amp;S 4-443, 630 West 168th Street, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Pathology and Cell Biology, Columbia University Medical Center, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hupf</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of Neurology, Columbia University Medical Center, Room P&amp;S 4-443, 630 West 168th Street, New York, NY, 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eleanor and Lou Gehrig ALS Center, Columbia University Medical Center, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zandkarimi</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Biological Sciences, Columbia University Medical Center, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>R B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Pathology and Cell Biology, Columbia University Medical Center, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mitsumoto</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Departments of Neurology, Columbia University Medical Center, Room P&amp;S 4-443, 630 West 168th Street, New York, NY, 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eleanor and Lou Gehrig ALS Center, Columbia University Medical Center, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG056387</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG045335</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES016348</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081362" MajorTopicYN="Y">Lipidomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34193885</ArticleId><ArticleId IdType="pmc">PMC8245424</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-92112-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-92112-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, Jamali MS, Atkin JD. Motor neuron susceptibility in ALS/FTD. Front. Neurosci. 2019;13:532. doi: 10.3389/fnins.2019.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS) Biochim. Biophys. Acta. 2015;1852:679&#x2013;684. doi: 10.1016/j.bbadis.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.010</ArticleId><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Robelin L, Gonzalez De Aguilar JL. Blood biomarkers for amyotrophic lateral sclerosis: myth or reality? Biomed. Res. Int. 2014;2014:525097. doi: 10.1155/2014/525097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/525097</ArticleId><ArticleId IdType="pmc">PMC4060749</ArticleId><ArticleId IdType="pubmed">24991560</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, et al. Amyotrophic lateral sclerosis diagnostic index: toward a personalized diagnosis of ALS. Neurology. 2019;92:e536&#x2013;e547. doi: 10.1212/WNL.0000000000006876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006876</ArticleId><ArticleId IdType="pubmed">30709964</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S. Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques. Int. J. Mol. Sci. 2019 doi: 10.3390/ijms20112818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112818</ArticleId><ArticleId IdType="pmc">PMC6600525</ArticleId><ArticleId IdType="pubmed">31185581</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology. 2009;72:1948&#x2013;1952. doi: 10.1212/WNL.0b013e3181a8269b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a8269b</ArticleId><ArticleId IdType="pubmed">19487653</ArticleId></ArticleIdList></Reference><Reference><Citation>Statland JM, Barohn RJ, Dimachkie MM, Floeter MK, Mitsumoto H. Primary lateral sclerosis. Neurol. Clin. 2015;33:749&#x2013;760. doi: 10.1016/j.ncl.2015.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.007</ArticleId><ArticleId IdType="pmc">PMC4628724</ArticleId><ArticleId IdType="pubmed">26515619</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol. Genet. 2015;1:e3. doi: 10.1212/01.NXG.0000464294.88607.dd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.NXG.0000464294.88607.dd</ArticleId><ArticleId IdType="pmc">PMC4821084</ArticleId><ArticleId IdType="pubmed">27066542</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph. Lateral Scler. Frontotemporal. Degener. 2019 doi: 10.1080/21678421.2018.1550518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550518</ArticleId><ArticleId IdType="pubmed">30654671</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, et al. Pattern of spread and prognosis in lower limb-onset ALS. Amyotroph. Lateral Scler. 2010;11:369&#x2013;373. doi: 10.3109/17482960903420140.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903420140</ArticleId><ArticleId IdType="pmc">PMC3182546</ArticleId><ArticleId IdType="pubmed">20001488</ArticleId></ArticleIdList></Reference><Reference><Citation>Cermenati G, et al. Lipids in the nervous system: from biochemistry and molecular biology to patho-physiology. Biochim. Biophys. Acta. 2015;1851:51&#x2013;60. doi: 10.1016/j.bbalip.2014.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2014.08.011</ArticleId><ArticleId IdType="pubmed">25150974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenk MR. Lipidomics in drug and biomarker development. Expert Opin. Drug Discov. 2006;1:723&#x2013;736. doi: 10.1517/17460441.1.7.723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17460441.1.7.723</ArticleId><ArticleId IdType="pubmed">23495996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, et al. ALS multicenter cohort study of oxidative stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:192&#x2013;203. doi: 10.3109/21678421.2013.864312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.864312</ArticleId><ArticleId IdType="pmc">PMC4310702</ArticleId><ArticleId IdType="pubmed">24564738</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009. doi: 10.1212/01.wnl.0000285080.70324.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000285080.70324.27</ArticleId><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann. Neurol. 2017;81:718&#x2013;728. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuberth F, Henseler J, Dijkstra TK. Partial least squares path modeling using ordinal categorical indicators. Qual. Quant. 2018;52:9&#x2013;35. doi: 10.1007/s11135-016-0401-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11135-016-0401-7</ArticleId><ArticleId IdType="pmc">PMC5794891</ArticleId><ArticleId IdType="pubmed">29416181</ArticleId></ArticleIdList></Reference><Reference><Citation>Worley B, Powers R. Multivariate analysis in metabolomics. Curr. Metab. 2013;1:92&#x2013;107. doi: 10.2174/2213235X11301010092.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2213235X11301010092</ArticleId><ArticleId IdType="pmc">PMC4465187</ArticleId><ArticleId IdType="pubmed">26078916</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez KM, Reinke SN, Broadhurst DI. A comparative evaluation of the generalised predictive ability of eight machine learning algorithms across ten clinical metabolomics data sets for binary classification. Metabolomics. 2019;15:150. doi: 10.1007/s11306-019-1612-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-019-1612-4</ArticleId><ArticleId IdType="pmc">PMC6856029</ArticleId><ArticleId IdType="pubmed">31728648</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomyen Y, et al. Deep metabolome: applications of deep learning in metabolomics. Comput. Struct. Biotechnol. J. 2020;18:2818&#x2013;2825. doi: 10.1016/j.csbj.2020.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2020.09.033</ArticleId><ArticleId IdType="pmc">PMC7575644</ArticleId><ArticleId IdType="pubmed">33133423</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri B, Alikhani A, Mokhtari H, Rasouli M. The ratio of unesterified/esterified cholesterol is the major determinant of atherogenicity of lipoprotein fractions. Med. Arch. 2018;72:103&#x2013;107. doi: 10.5455/medarh.2018.72.103-107.</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/medarh.2018.72.103-107</ArticleId><ArticleId IdType="pmc">PMC5911171</ArticleId><ArticleId IdType="pubmed">29736097</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerl MJ, et al. Cholesterol is inefficiently converted to cholesteryl esters in the blood of cardiovascular disease patients. Sci. Rep. 2018;8:14764. doi: 10.1038/s41598-018-33116-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33116-4</ArticleId><ArticleId IdType="pmc">PMC6170447</ArticleId><ArticleId IdType="pubmed">30282999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioumourtzoglou MA, et al. Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: a population based study. Amyotroph. Lateral Scler. Frontotemporal Degener. 2016;17:548&#x2013;554. doi: 10.1080/21678421.2016.1208247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1208247</ArticleId><ArticleId IdType="pmc">PMC5178102</ArticleId><ArticleId IdType="pubmed">27436717</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas HE, Jr, Kannel WB, Dawber TR, McNamara PM. Cholesterol-phospholipid ratio in the prediction of coronary heart disease. The framingham study. N. Engl. J. Med. 1966;274:701&#x2013;705. doi: 10.1056/NEJM196603312741302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196603312741302</ArticleId><ArticleId IdType="pubmed">5908872</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucci S, Behringer S, De Spiekerkoetter U. novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids. FEBS J. 2015;282:4242&#x2013;4253. doi: 10.1111/febs.13418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13418</ArticleId><ArticleId IdType="pubmed">26284828</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R, et al. Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol. Appl. Neurobiol. 2015;41:201&#x2013;226. doi: 10.1111/nan.12147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12147</ArticleId><ArticleId IdType="pmc">PMC4329387</ArticleId><ArticleId IdType="pubmed">24750211</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KC, et al. Dietary omega-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:1102&#x2013;1110. doi: 10.1001/jamaneurol.2014.1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1214</ArticleId><ArticleId IdType="pmc">PMC4160351</ArticleId><ArticleId IdType="pubmed">25023276</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J. Neurol. 2011;258:613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri E, et al. Circulating ceramides are inversely associated with cardiorespiratory fitness in participants aged 54&#x2013;96 years from the Baltimore longitudinal study of aging. Aging Cell. 2016;15:825&#x2013;831. doi: 10.1111/acel.12491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12491</ArticleId><ArticleId IdType="pmc">PMC5013023</ArticleId><ArticleId IdType="pubmed">27135629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergman BC, et al. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. Am. J. Physiol. Endocrinol. Metab. 2015;309:E398&#x2013;408. doi: 10.1152/ajpendo.00134.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00134.2015</ArticleId><ArticleId IdType="pmc">PMC4537923</ArticleId><ArticleId IdType="pubmed">26126684</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:166&#x2013;171. doi: 10.3109/17482960902822960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SJ, et al. Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection. Int. J. Infect. Dis. 2015;33:149&#x2013;155. doi: 10.1016/j.ijid.2015.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2015.01.020</ArticleId><ArticleId IdType="pubmed">25625177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghidoni R, Caretti A, Signorelli P. Role of Sphingolipids in the Pathobiology of Lung Inflammation. Mediators Inflamm. 2015;2015:487508. doi: 10.1155/2015/487508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/487508</ArticleId><ArticleId IdType="pmc">PMC4681829</ArticleId><ArticleId IdType="pubmed">26770018</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeba R, et al. Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging. J. Atheroscler. Thromb. 2007;14:12&#x2013;18. doi: 10.5551/jat.14.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.14.12</ArticleId><ArticleId IdType="pubmed">17332687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho AB, et al. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci. Rep. 2019;9:11642. doi: 10.1038/s41598-019-48059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48059-7</ArticleId><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Slotte JP, Bierman EL. Movement of plasma-membrane sterols to the endoplasmic reticulum in cultured cells. Biochem. J. 1987;248:237&#x2013;242. doi: 10.1042/bj2480237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2480237</ArticleId><ArticleId IdType="pmc">PMC1148524</ArticleId><ArticleId IdType="pubmed">3435441</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J, Bjorklund E, Nielsen FK, Hansen M. Incorporation of (14)C-cholesterol in human adrenal corticocarcinoma H295R cell line and online-radiodetection of produced (14)C-steroid hormone metabolites. J. Pharm. Biomed. Anal. 2017;145:569&#x2013;575. doi: 10.1016/j.jpba.2017.06.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2017.06.058</ArticleId><ArticleId IdType="pubmed">28777968</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Khalik J, et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J. Lipid Res. 2017;58:267&#x2013;278. doi: 10.1194/jlr.P071639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.P071639</ArticleId><ArticleId IdType="pmc">PMC5234729</ArticleId><ArticleId IdType="pubmed">27811233</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbaiah PV, et al. Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity. Biochim. Biophys. Acta. 2012;1821:908&#x2013;913. doi: 10.1016/j.bbalip.2012.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2012.02.007</ArticleId><ArticleId IdType="pmc">PMC3340435</ArticleId><ArticleId IdType="pubmed">22370449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, et al. APOE: a potential marker of disease progression in ALS. Neurology. 2002;58:1112&#x2013;1114. doi: 10.1212/WNL.58.7.1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.58.7.1112</ArticleId><ArticleId IdType="pubmed">11940705</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres-Benito P, Moreno J, Aso E, Povedano M, Ferrer I. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration. Aging (Albany NY) 2017;9:823&#x2013;851. doi: 10.18632/aging.101195.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101195</ArticleId><ArticleId IdType="pmc">PMC5391234</ArticleId><ArticleId IdType="pubmed">28283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sysi-Aho M, et al. Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles. Bioinformatics. 2007;23:i519&#x2013;528. doi: 10.1093/bioinformatics/btm181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btm181</ArticleId><ArticleId IdType="pubmed">17646339</ArticleId></ArticleIdList></Reference><Reference><Citation>Field FJ, Albright E, Mathur SN. Regulation of triglyceride-rich lipoprotein secretion by fatty acids in CaCo-2 cells. J. Lipid Res. 1988;29:1427&#x2013;1437. doi: 10.1016/S0022-2275(20)38423-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2275(20)38423-6</ArticleId><ArticleId IdType="pubmed">3241120</ArticleId></ArticleIdList></Reference><Reference><Citation>Nodera H, et al. Frequent hepatic steatosis in amyotrophic lateral sclerosis: implication for systemic involvement. Neurol. Clin. Neurosci. 2015;3:58&#x2013;62. doi: 10.1111/ncn3.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.143</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietilainen KH, et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects&#x2013;a monozygotic twin study. PLoS ONE. 2007;2:e218. doi: 10.1371/journal.pone.0000218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000218</ArticleId><ArticleId IdType="pmc">PMC1789242</ArticleId><ArticleId IdType="pubmed">17299598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kioumourtzoglou MA, et al. Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study. JAMA Neurol. 2015;72:905&#x2013;911. doi: 10.1001/jamaneurol.2015.0910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.0910</ArticleId><ArticleId IdType="pmc">PMC4975611</ArticleId><ArticleId IdType="pubmed">26030836</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, et al. Blood cell palmitoleate-palmitate ratio is an independent prognostic factor for amyotrophic lateral sclerosis. PLoS ONE. 2015;10:e0131512. doi: 10.1371/journal.pone.0131512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0131512</ArticleId><ArticleId IdType="pmc">PMC4492495</ArticleId><ArticleId IdType="pubmed">26147510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerman D, et al. Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 2018;24:2596&#x2013;2605. doi: 10.1016/j.celrep.2018.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.08.015</ArticleId><ArticleId IdType="pmc">PMC6137821</ArticleId><ArticleId IdType="pubmed">30184495</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Szelechowski M, et al. Metabolic reprogramming in amyotrophic lateral sclerosis. Sci. Rep. 2018;8:3953. doi: 10.1038/s41598-018-22318-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22318-5</ArticleId><ArticleId IdType="pmc">PMC5834494</ArticleId><ArticleId IdType="pubmed">29500423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, et al. Body mass index and amyotrophic lateral sclerosis: a study of US military veterans. Am. J. Epidemiol. 2017;185:362&#x2013;371. doi: 10.1093/aje/kww140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kww140</ArticleId><ArticleId IdType="pmc">PMC5860019</ArticleId><ArticleId IdType="pubmed">28158443</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, et al. Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease. PLoS ONE. 2012;7:e49191. doi: 10.1371/journal.pone.0049191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049191</ArticleId><ArticleId IdType="pmc">PMC3492315</ArticleId><ArticleId IdType="pubmed">23145119</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, et al. Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase. Hum. Mol. Genet. 2015;24:7390&#x2013;7405. doi: 10.1093/hmg/ddv439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv439</ArticleId><ArticleId IdType="pmc">PMC4664174</ArticleId><ArticleId IdType="pubmed">26483191</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, et al. Inhibition of beta-glucocerebrosidase activity preserves motor unit integrity in a mouse model of amyotrophic lateral sclerosis. Sci. Rep. 2017;7:5235. doi: 10.1038/s41598-017-05313-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05313-0</ArticleId><ArticleId IdType="pmc">PMC5507914</ArticleId><ArticleId IdType="pubmed">28701774</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, et al. Lipidomics reveals cerebrospinal-fluid signatures of ALS. Sci. Rep. 2017;7:17652. doi: 10.1038/s41598-017-17389-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17389-9</ArticleId><ArticleId IdType="pmc">PMC5732162</ArticleId><ArticleId IdType="pubmed">29247199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 2002;52:448&#x2013;457. doi: 10.1002/ana.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10312</ArticleId><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz LX, et al. The lipid-modifying enzyme SMPDL3B negatively regulates innate immunity. Cell Rep. 2015;11:1919&#x2013;1928. doi: 10.1016/j.celrep.2015.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.05.006</ArticleId><ArticleId IdType="pmc">PMC4508342</ArticleId><ArticleId IdType="pubmed">26095358</ArticleId></ArticleIdList></Reference><Reference><Citation>Koberlin MS, et al. A conserved circular network of coregulated lipids modulates innate immune responses. Cell. 2015;162:170&#x2013;183. doi: 10.1016/j.cell.2015.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.05.051</ArticleId><ArticleId IdType="pmc">PMC4523684</ArticleId><ArticleId IdType="pubmed">26095250</ArticleId></ArticleIdList></Reference><Reference><Citation>Arima H, et al. Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model. Neuroscience. 2015;297:127&#x2013;136. doi: 10.1016/j.neuroscience.2015.03.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.03.060</ArticleId><ArticleId IdType="pubmed">25841322</ArticleId></ArticleIdList></Reference><Reference><Citation>Veyrat-Durebex C, et al. Metabo-lipidomics of fibroblasts and mitochondrial-endoplasmic reticulum extracts from ALS patients shows alterations in purine, pyrimidine, energetic, and phospholipid metabolisms. Mol. Neurobiol. 2019;56:5780&#x2013;5791. doi: 10.1007/s12035-019-1484-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1484-7</ArticleId><ArticleId IdType="pubmed">30680691</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance JE. MAM (mitochondria-associated membranes) in mammalian cells: Lipids and beyond. Biochim. Biophys. Acta. 2014;1841:595&#x2013;609. doi: 10.1016/j.bbalip.2013.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2013.11.014</ArticleId><ArticleId IdType="pubmed">24316057</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, et al. Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol. Med. 2016;8:1421&#x2013;1437. doi: 10.15252/emmm.201606403.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606403</ArticleId><ArticleId IdType="pmc">PMC5167132</ArticleId><ArticleId IdType="pubmed">27821430</ArticleId></ArticleIdList></Reference><Reference><Citation>Paillusson S, et al. There's something wrong with my MAM; the ER-mitochondria axis and neurodegenerative diseases. Trends Neurosci. 2016;39:146&#x2013;157. doi: 10.1016/j.tins.2016.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2016.01.008</ArticleId><ArticleId IdType="pmc">PMC4780428</ArticleId><ArticleId IdType="pubmed">26899735</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieves JW, et al. Association between dietary intake and function in amyotrophic lateral sclerosis. JAMA Neurol. 2016;73:1425&#x2013;1432. doi: 10.1001/jamaneurol.2016.3401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.3401</ArticleId><ArticleId IdType="pmc">PMC5370581</ArticleId><ArticleId IdType="pubmed">27775751</ArticleId></ArticleIdList></Reference><Reference><Citation>Burla B, et al. MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines. J. Lipid Res. 2018;59:2001&#x2013;2017. doi: 10.1194/jlr.S087163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.S087163</ArticleId><ArticleId IdType="pmc">PMC6168311</ArticleId><ArticleId IdType="pubmed">30115755</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedes LC, et al. Serum lipid alterations in GBA-associated Parkinson's disease. Parkinsonism Relat. Disord. 2017;44:58&#x2013;65. doi: 10.1016/j.parkreldis.2017.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2017.08.026</ArticleId><ArticleId IdType="pubmed">28890071</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan RB, et al. Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J. Biol. Chem. 2012;287:2678&#x2013;2688. doi: 10.1074/jbc.M111.274142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.274142</ArticleId><ArticleId IdType="pmc">PMC3268426</ArticleId><ArticleId IdType="pubmed">22134919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sysi-Aho M, Katajamaa M, Yetukuri L, Oresic M. Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinform. 2007;8:93. doi: 10.1186/1471-2105-8-93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-8-93</ArticleId><ArticleId IdType="pmc">PMC1838434</ArticleId><ArticleId IdType="pubmed">17362505</ArticleId></ArticleIdList></Reference><Reference><Citation>Thevenot EA, Roux A, Xu Y, Ezan E, Junot C. Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J. Proteome Res. 2015;14:3322&#x2013;3335. doi: 10.1021/acs.jproteome.5b00354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.5b00354</ArticleId><ArticleId IdType="pubmed">26088811</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>